semaglutide and suicidal thoughts found to increase risk of Glucagon-like peptide-1 receptor agonists and

These findings align with both clinical trial data and prior real-world studies

Many people wonder whether they can achieve lasting weight loss while staying on a lower semaglutide dose

These recommendations are based on their potential benefits and how they can complement GLP-1 therapy to enhance health outcomes

With its new free tier featuring daily microhabits and access to microdose GLP-1s, Noom is democratizing prev

Restless legs syndrome (RLS) is a neurological disorder marked by symptoms of unpleasant sensations and an uncontrollable desire to move the legs.

Results: Average ~20-22% body weight loss (based on SURMOUNT trials)